The Lancet Regional Health. Western Pacific (Nov 2023)
Evaluation of cross-neutralizing antibodies in children infected with omicron sub-variants
- Weiyu Peng,
- Xiaopeng Ma,
- Kun Tan,
- Hongmei Wang,
- Mengqing Cong,
- Yanan Zhang,
- Shuguang Tan,
- Xin Zhao,
- George F. Gao,
- Jikui Deng
Affiliations
- Weiyu Peng
- Department of Infectious Diseases, Shenzhen Children’s Hospital, Shenzhen 518038, China; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China
- Xiaopeng Ma
- Office of President, Shenzhen Children’s Hospital, Shenzhen 518038, China
- Kun Tan
- Department of Infectious Diseases, Shenzhen Children’s Hospital, Shenzhen 518038, China
- Hongmei Wang
- Department of Infectious Diseases, Shenzhen Children’s Hospital, Shenzhen 518038, China
- Mengqing Cong
- Department of Infectious Diseases, Shenzhen Children’s Hospital, Shenzhen 518038, China; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China
- Yanan Zhang
- Department of Infectious Diseases, Shenzhen Children’s Hospital, Shenzhen 518038, China; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China
- Shuguang Tan
- CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China
- Xin Zhao
- CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China; Corresponding author.
- George F. Gao
- CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China; Corresponding author.
- Jikui Deng
- Department of Infectious Diseases, Shenzhen Children’s Hospital, Shenzhen 518038, China; Corresponding author.
- Journal volume & issue
-
Vol. 40
p. 100939